C4 Therapeutics (CCCC) Financials: Revenue & Earnings
CCCC$3.44+0.23 +7.01%
$422.59M
Market Cap
-2.98
P/E
4.67
Forward P/E
56
Score
C4 Therapeutics (CCCC) Financials: Revenue & Earnings
CCCC price $3.44 +0.23 +7.01%
- Ticker
- CCCC
- Price
- $3.44
- Change
- +0.23 +7.01%
- Market cap ?
- $422.59M
- P/E ?
- -2.98
- Forward P/E ?
- 4.67
- Dividend yield ?
- 0.00%
- Beta ?
- 3.08
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 56
- Value
- 58
- Quality
- 47
- Growth
- 62
Stocklytics score rationale: value 58, quality 47, growth 62.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 19364000 | 21381000 | 33195000 | 45785000 | 31096000 | 20756000 | 35584000 | 35947000 |
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins implicated in disease, addressing a range of conditions including cancer, neurodegenerative disorders, and other illnesses. The company's primary drug candidate, CFT7455, is an orally administered MonoDAC degrader of the IKZF1 and…
Fair value
CCCC fair value $14.67. Price $3.44. Price is 77% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 6.07M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 123.02M. Net debt -14.62M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.20 | — | 8.85M |
| 2026-08-11 | -0.18 | -0.23 | 6.64M | 4.00M |
| 2026-05-12 | -0.20 | -0.25 | 6.20M | 4.42M |
| 2026-02-26 | -0.18 | -0.31 | 11.02M | 5.39M |
| 2025-11-06 | -0.44 | -0.41 | 11.20M | 6.28M |
| 2025-08-07 | -0.37 | -0.38 | 6.46M | 6.55M |
| 2025-05-06 | -0.37 | -0.48 | 7.20M | 4.45M |
| 2025-02-27 | -0.49 | -0.45 | 5.18M | 5.09M |
| 2024-10-31 | -0.35 | -0.38 | 15.40M | 5.90M |
| 2024-08-01 | -0.26 | -0.37 | 12.01M | 4.78M |
| 2024-05-08 | -0.41 | -0.41 | 3.04M | 11.99M |
| 2024-02-21 | -0.70 | -0.68 | 3.27M | 3.20M |
| 2023-11-01 | -0.52 | -0.66 | 11.07M | 5.28M |
| 2023-08-08 | -0.73 | -0.69 | 2.66M | 6.41M |
| 2023-05-04 | -0.71 | -0.75 | 3.76M | 5.46M |
| 2023-02-23 | -0.77 | -0.74 | 2.85M | 9.87M |
| 2022-11-03 | -0.65 | -0.67 | 6.75M | 8.45M |
| 2022-08-04 | -0.56 | -0.69 | 13.80M | 7.64M |
| 2022-05-05 | -0.65 | -0.58 | 7.65M | 7.81M |
| 2022-02-24 | -0.31 | -0.58 | 20.08M | 7.41M |
| 2021-11-10 | -0.51 | -0.59 | 8.50M | 9.78M |
| 2021-08-11 | -0.51 | -0.59 | 9.78M | 6.02M |
| 2021-05-13 | -0.49 | -0.63 | 7.43M | 9.08M |
| 2021-03-11 | -0.04 | -0.53 | 8.26M | 8.00M |
| 2020-11-12 | -17.55 | -0.79 | 8.45M | 153.68M |
| 2020-10-02 | -0.26 | — | 9.67M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Anderson Kenneth Carl | Buy | 3.66K | $3.14 | 11.50K |
| 2026-10-01 | GROGAN DONNA ROY | Buy | 4.62K | $3.14 | 14.50K |
| 2026-09-18 | Adams Kendra | Buy | 6.25K | — | — |
| 2026-09-18 | Adams Kendra | Sell | 2.77K | $3.39 | 9.41K |
| 2026-07-10 | REYNO LEONARD | Buy | 15.32K | — | — |
| 2026-07-10 | REYNO LEONARD | Sell | 7.40K | $4.06 | 30.03K |
| 2026-07-01 | Anderson Kenneth Carl | Buy | 2.65K | $4.34 | 11.50K |
| 2026-07-01 | GROGAN DONNA ROY | Buy | 3.34K | $4.34 | 14.50K |
| 2026-06-24 | Hughes Owen | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | Hoerter Steven L. | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | Koppikar Utpal | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | Anderson Kenneth Carl | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | Cooper Ronald Harold Wilfred | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | Bessen Laura | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | Fawell Stephen | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-24 | GROGAN DONNA ROY | Buy | 62.00K | $4.25 | 263.50K |
| 2026-06-01 | Anderson Kenneth Carl | Buy | 1.07K | $2.11 | 2.26K |
| 2026-06-01 | Anderson Kenneth Carl | Sell | 1.07K | $2.11 | 2.26K |
| 2026-04-01 | Anderson Kenneth Carl | Buy | 4.26K | $2.70 | 11.50K |
| 2026-04-01 | GROGAN DONNA ROY | Buy | 5.37K | $2.70 | 14.50K |
| 2026-02-15 | Hirsch Andrew | Buy | 20.40K | — | — |
| 2026-02-15 | Hirsch Andrew | Sell | 9.06K | $1.89 | 17.12K |
| 2026-02-14 | Boyle Scott N | Buy | 20.95K | — | — |
| 2026-02-14 | Boyle Scott N | Sell | 7.27K | $1.89 | 13.74K |
| 2026-02-14 | Mahaney Paige | Buy | 7.05K | — | — |
| 2026-02-14 | Mahaney Paige | Sell | 2.45K | $1.89 | 4.62K |
| 2026-02-14 | Schick Kelly | Buy | 20.95K | — | — |
| 2026-02-14 | Schick Kelly | Sell | 7.27K | $1.89 | 13.74K |
| 2026-02-14 | Hirsch Andrew | Buy | 81.72K | — | — |
| 2026-02-14 | Hirsch Andrew | Sell | 39.15K | $1.89 | 74.00K |
| 2026-02-14 | REYNO LEONARD | Buy | 30.95K | — | — |
| 2026-02-14 | REYNO LEONARD | Sell | 16.58K | $1.89 | 31.33K |
| 2026-02-14 | Adams Kendra | Buy | 30.95K | — | — |
| 2026-02-14 | Adams Kendra | Sell | 15.38K | $1.89 | 29.07K |
| 2026-02-14 | Mossler Mark | Buy | 9.42K | — | — |
| 2026-02-14 | Mossler Mark | Sell | 3.27K | $1.89 | 6.18K |
| 2026-02-13 | Boyle Scott N | Buy | 5.00K | — | — |
| 2026-02-13 | Boyle Scott N | Buy | 200.00K | — | — |
| 2026-02-13 | Boyle Scott N | Sell | 1.74K | $1.89 | 3.28K |
| 2026-02-13 | Mahaney Paige | Buy | 240.00K | — | — |
| 2026-02-13 | Schick Kelly | Buy | 200.00K | — | — |
| 2026-02-13 | Schick Kelly | Buy | 5.00K | — | — |
| 2026-02-13 | Schick Kelly | Sell | 1.74K | $1.89 | 3.28K |
| 2026-02-13 | Hirsch Andrew | Buy | 700.00K | — | — |
| 2026-02-13 | REYNO LEONARD | Buy | 240.00K | — | — |
| 2026-02-13 | Adams Kendra | Buy | 240.00K | — | — |
| 2026-02-13 | Adams Kendra | Buy | 3.75K | — | — |
| 2026-02-13 | Adams Kendra | Sell | 1.86K | $1.89 | 3.52K |
| 2026-02-13 | Mossler Mark | Buy | 56.98K | — | — |
| 2026-01-16 | REYNO LEONARD | Sell | 10.00K | $2.22 | 22.20K |
| 2026-01-02 | Anderson Kenneth Carl | Buy | 5.96K | $1.93 | 11.50K |
| 2026-01-02 | GROGAN DONNA ROY | Buy | 7.51K | $1.93 | 14.50K |
| 2025-10-28 | Mahaney Paige | Buy | 19.20K | — | — |
| 2025-10-28 | Mahaney Paige | Sell | 5.64K | $2.58 | 14.56K |
| 2025-10-01 | Anderson Kenneth Carl | Buy | 5.35K | $2.15 | 11.50K |
| 2025-10-01 | GROGAN DONNA ROY | Buy | 6.74K | $2.15 | 14.49K |
| 2025-09-18 | Adams Kendra | Buy | 6.25K | — | — |
| 2025-09-18 | Adams Kendra | Sell | 2.77K | $3.32 | 9.21K |
| 2025-07-10 | REYNO LEONARD | Buy | 15.32K | — | — |
| 2025-07-10 | REYNO LEONARD | Sell | 7.38K | $1.99 | 14.69K |
| 2025-07-01 | Anderson Kenneth Carl | Buy | 7.62K | $1.51 | 11.50K |
| 2025-07-01 | GROGAN DONNA ROY | Buy | 9.61K | $1.51 | 14.51K |
| 2025-06-18 | Koppikar Utpal | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | Hughes Owen | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | Fawell Stephen | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | Anderson Kenneth Carl | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | Bessen Laura | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | GROGAN DONNA ROY | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | Cooper Ronald Harold Wilfred | Buy | 35.50K | $1.44 | 51.12K |
| 2025-06-18 | Hoerter Steven L. | Buy | 35.50K | $1.44 | 51.12K |
| 2025-04-01 | GROGAN DONNA ROY | Buy | 9.58K | $1.44 | 13.75K |
| 2025-04-01 | Anderson Kenneth Carl | Buy | 7.84K | $1.44 | 11.25K |
| 2025-02-18 | Boyle Scott N | Sell | 669 | $3.15 | 2.11K |
| 2025-02-15 | Hirsch Andrew | Sell | 9.37K | $3.18 | 29.80K |
| 2025-02-14 | Hirsch Andrew | Buy | 223.50K | — | — |
| 2025-02-14 | Hirsch Andrew | Sell | 12.85K | $3.18 | 40.85K |
| 2025-02-14 | Hirsch Andrew | Buy | 335.30K | $3.18 | 1.07M |
| 2025-02-14 | Siegel Jolie | Buy | 56.50K | — | — |
| 2025-02-14 | Siegel Jolie | Sell | 2.91K | $3.18 | 9.27K |
| 2025-02-14 | Siegel Jolie | Buy | 84.70K | $3.18 | 269.35K |
| 2025-02-14 | Boyle Scott N | Buy | 56.50K | — | — |
| 2025-02-14 | Boyle Scott N | Sell | 490 | $3.15 | 1.54K |
| 2025-02-14 | Boyle Scott N | Sell | 2.37K | $3.18 | 7.53K |
| 2025-02-14 | Boyle Scott N | Buy | 84.70K | $3.18 | 269.35K |
| 2025-02-14 | Mossler Mark | Sell | 1.59K | $3.18 | 5.04K |
| 2025-02-14 | Schick Kelly | Buy | 56.50K | — | — |
| 2025-02-14 | Schick Kelly | Sell | 2.37K | $3.18 | 7.53K |
| 2025-02-14 | Schick Kelly | Buy | 84.70K | $3.18 | 269.35K |
| 2025-02-14 | Adams Kendra | Buy | 87.10K | — | — |
| 2025-02-14 | Adams Kendra | Sell | 4.56K | $3.18 | 14.50K |
| 2025-02-14 | Adams Kendra | Buy | 130.60K | $3.18 | 415.31K |
| 2025-02-14 | Mahaney Paige | Buy | 28.20K | — | — |
| 2025-02-14 | Mahaney Paige | Buy | 42.40K | $3.18 | 134.83K |
| 2025-02-14 | REYNO LEONARD | Buy | 87.10K | — | — |
| 2025-02-14 | REYNO LEONARD | Sell | 5.14K | $3.18 | 16.36K |
| 2025-02-14 | REYNO LEONARD | Buy | 130.60K | $3.18 | 415.31K |
| 2025-02-13 | Siegel Jolie | Sell | 2.13K | $3.20 | 6.83K |
| 2025-02-13 | Boyle Scott N | Sell | 1.74K | $3.20 | 5.55K |
| 2025-02-13 | Schick Kelly | Sell | 1.74K | $3.20 | 5.55K |
| 2025-02-13 | Adams Kendra | Sell | 1.86K | $3.20 | 5.96K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 158, holders +30 vs prior quarter. Ownership 93.98%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| MORGAN STANLEY | 8.87M | -205.06K | -2.26% | 41.41M |
| RA CAPITAL MANAGEMENT, L.P. | 8.00M | 0 | 0.00% | 37.36M |
| BLACKROCK, INC. | 7.90M | 5.85M | +285.48% | 36.88M |
| LYNX1 CAPITAL MANAGEMENT LP | 7.33M | 327.79K | +4.68% | 34.22M |
| SQUADRON CAPITAL MANAGEMENT LLC | 7.20M | 4.95M | +220.00% | 33.62M |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 7.17M | 0 | 0.00% | 33.49M |
| JPMORGAN CHASE & CO | 4.75M | 1.52M | +47.30% | 20.65M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.42M | 555.88K | +14.39% | 20.63M |
| CITADEL ADVISORS LLC | 4.19M | 4.15M | +12363.04% | 19.56M |
| GOLDMAN SACHS GROUP INC | 3.53M | 1.14M | +47.90% | 16.49M |
| WASATCH ADVISORS LP | 3.52M | 560.88K | +18.94% | 16.45M |
| TWO SIGMA INVESTMENTS, LP | 3.47M | 434.07K | +14.30% | 16.20M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 3.38M | -425.96K | -11.20% | 15.78M |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3.03M | 1.12M | +58.60% | 14.16M |
| BANK OF AMERICA CORP /DE/ | 2.66M | 297.12K | +12.59% | 12.41M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.52M | 1.57M | +165.20% | 11.78M |
| IKARIAN CAPITAL, LLC | 2.43M | 2.43M | New | 11.36M |
| STATE STREET CORP | 2.12M | 1.73M | +452.42% | 9.88M |
| ACADIAN ASSET MANAGEMENT LLC | 1.81M | -84.72K | -4.48% | 8.43M |
| CANDRIAM S.C.A. | 1.80M | 1.80M | New | 8.38M |
| D. E. SHAW & CO., INC. | 1.74M | 680.66K | +64.19% | 8.13M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.73M | 1.62M | +1509.86% | 8.09M |
| PATIENT SQUARE CAPITAL LP | 1.61M | 1.61M | New | 7.51M |
| HIGHVISTA STRATEGIES LLC | 1.35M | 1.35M | New | 6.30M |
| RENAISSANCE TECHNOLOGIES LLC | 1.19M | -1.27M | -51.67% | 5.56M |
Earnings and financials
C4 Therapeutics, Inc. (CCCC) trades at $3.44, with a market cap of $422.59M and a trailing P/E of -2.98. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 19364000 | 21381000 | 33195000 | 45785000 | 31096000 | 20756000 | 35584000 | 35947000 |
Insights · Dividends · Forecast · Financials · Learn